Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today announced a proposal to establish procedures and criteria for the de novo classification of medical devices, including in vitro diagnostics. 

FDA Commissioner Scott Gottlieb said in a statement that the agency's goal is to make the pathway "significantly more efficient and transparent by clarifying the requirements for submission and our processes for review."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.